BIOXYTRAN, INC (72) | Uncategorized (5)

Recent Contracts

Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022 (Filed With SEC on June 10, 2022)
Form of Private Placement Memorandum dated February 26, 2021 (Filed With SEC on November 17, 2021)
Form of Subsidiary Option dated June 4, 2021 (Filed With SEC on November 17, 2021)
Form of Private Placement Memorandum dated September 17, 2021 (Filed With SEC on November 17, 2021)
Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019 (Filed With SEC on April 26, 2019)